Stem Cells, Vol 12, 563-576, Copyright © 1994 by AlphaMed Press

REVIEWS

Gene transfer into hematopoietic progenitor and stem cells: progress and problems

CE Dunbar and RV Emmons
Hematology Branch, National Heart, Lung and Blood Institute, Bethesda, MD 20892.

Gene transfer to hematopoietic cells for the purpose of "gene therapy" is a new and rapidly developing field with clinical trials in progress. A fundamental goal of research in this field is the incorporation of exogenous genes into the chromosomes of the most primitive hematopoietic progenitor cells--stem cells. Recombinantly engineered retroviral vectors are the best characterized and are currently the only vector type in clinical trials directed at the hematopoietic system. High efficiency gene transfer and expression in murine stem cells and their progeny is now routine, but in larger animal models such as dogs or primates and preliminary clinical trials, gene transfer has been less successful. Problems such as retroviral efficiency, gene expression, insertional mutagenesis and helper virus contamination are being addressed. A promising new vector, the adeno-associated virus (AAV), has shown promise and may allow production of high titer, stable, recombinant virions without helper contamination and with potentially better safety parameters. However, the technology for AAV gene transfer is currently underdeveloped, and issues related to the reproducible production of vectors must be addressed. Other non-viral vector systems are being explored, but little data are available on applications to hematopoietic cells. Better preclinical models are needed to study gene targeting and expression in human cells. An overview of recombinant retroviral and adeno-associated viral vector production, preclinical data and preliminary clinical data will be given, and problems needing to be addressed at all stages of development before broad clinical utility can be achieved will be discussed.

This article has been cited by other articles:

				B. C. Heng, H. Liu, and T. Cao Potential Benefits of Co-transplanting Autologous Adult Stem Cells Together with Human Embryonic Stem Cells or Their Differentiated Derivatives Ann. Clin. Lab. Sci., January 1, 2005; 35(1): 3 - 6. [Full Text] [PDF]

				T. S. Hawley, W. G. Telford, and R. G. Hawley "Rainbow" Reporters for Multispectral Marking and Lineage Analysis of Hematopoietic Stem Cells Stem Cells, February 1, 2001; 19(2): 118 - 124. [Abstract] [Full Text]

				R. Huss Isolation of Primary and Immortalized CD34- Hematopoietic and Mesenchymal Stem Cells from Various Sources Stem Cells, January 1, 2000; 18(1): 1 - 9. [Abstract] [Full Text]

				R. E. Sutton, H. T. M. Wu, R. Rigg, E. Bohnlein, and P. O. Brown Human Immunodeficiency Virus Type 1 Vectors Efficiently Transduce Human Hematopoietic Stem Cells J. Virol., July 1, 1998; 72(7): 5781 - 5788. [Abstract] [Full Text] [PDF]

				J. BERTRAN, Y. YANG, P. HARGROVE, E. F. VANIN, and A. W. NIENHUIS Targeted Integration of a Recombinant Globin Gene Adeno-Associated Viral Vector into Human Chromosome 19 Ann. N.Y. Acad. Sci., June 30, 1998; 850(1): 163 - 177. [Abstract] [Full Text] [PDF]

				K. Ito, Y. Ueda, M. Kokubun, M. Urabe, T. Inaba, H. Mano, H. Hamada, T. Kitamura, H. Mizoguchi, T. Sakata, et al. Development of a Novel Selective Amplifier Gene for Controllable Expansion of Transduced Hematopoietic Cells Blood, November 15, 1997; 90(10): 3884 - 3892. [Abstract] [Full Text] [PDF]

				M. F.A. Bierhuizen, Y. Westerman, T. P. Visser, W. Dimjati, A. W. Wognum, and G. Wagemaker Enhanced Green Fluorescent Protein as Selectable Marker of Retroviral-Mediated Gene Transfer in Immature Hematopoietic Bone Marrow Cells Blood, November 1, 1997; 90(9): 3304 - 3315. [Abstract] [Full Text] [PDF]

				E. Feldman, T. Ahmed, J.D. Lutton, T. Farley, K. Tani, M. Freund, S. Asano, and N.G. Abraham Adenovirus Mediated Alpha Interferon (IFN-{alpha}) Gene Transfer into CD34+ Cells and CML Mononuclear Cells Stem Cells, September 1, 1997; 15(5): 386 - 395. [Abstract] [Full Text]

				R.V.B. Emmons, S. Doren, J. Zujewski, M. Cottler-Fox, C.S. Carter, K. Hines, J.A. O'Shaughnessy, S.F. Leitman, J.J. Greenblatt, K. Cowan, et al. Retroviral Gene Transduction of Adult Peripheral Blood or Marrow-Derived CD34+ Cells for Six Hours Without Growth Factors or on Autologous Stroma Does Not Improve Marking Efficiency Assessed In Vivo Blood, June 1, 1997; 89(11): 4040 - 4046. [Abstract] [Full Text] [PDF]

				J. L. Abkowitz, S. N. Catlin, and P. Guttorp Strategies for Hematopoietic Stem Cell Gene Therapy: Insights From Computer Simulation Studies Blood, May 1, 1997; 89(9): 3192 - 3198. [Abstract] [Full Text] [PDF]

				P. W. Hargrove, E. F. Vanin, G. J. Kurtzman, and A. W. Nienhuis High-Level Globin Gene Expression Mediated by a Recombinant Adeno-Associated Virus Genome That Contains the 3' gamma  Globin Gene Regulatory Element and Integrates as Tandem Copies in Erythroid Cells Blood, March 15, 1997; 89(6): 2167 - 2175. [Abstract] [Full Text] [PDF]

				S. Yurasov, T. R. Kollmann, A. Kim, C. A. Raker, M. Hachamovitch, F. Wong-Staal, and H. Goldstein Severe Combined Immunodeficiency Mice Engrafted With Human T Cells, B Cells, and Myeloid Cells After Transplantation With Human Fetal Bone Marrow or Liver Cells and Implanted With Human Fetal Thymus: A Model for Studying Human Gene Therapy Blood, March 1, 1997; 89(5): 1800 - 1810. [Abstract] [Full Text] [PDF]

				L.-S. Lu, S.-J. Wang, and R. Auerbach In vitro and in vivo differentiation into B cells, T cells, and myeloid cells of primitive yolk sac hematopoietic precursor cells expanded >100-fold by coculture with a clonal yolk sac endothelial cell line PNAS, December 10, 1996; 93(25): 14782 - 14787. [Abstract] [Full Text] [PDF]

				R Auerbach, H Huang, and L Lu Hematopoietic stem cells in the mouse embryonic yolk sac Stem Cells, May 1, 1996; 14(3): 269 - 280. [Abstract]